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1. Na+ -H+ Exchange in RBC 
CHAPI'ER I 
INTRODUCTION 
The Na+ -H+ exchange ion transport pathway is the exchange of intracellular H+ with 
Na+ present in the plasma or in the suspension medium. Na+-H+ exchange plays an important 
role in regulation of intracellular pH (pH;), cell volume and transmembrane ion transport (1). 
A cellular acidification increases the activity of the exchanger, thus allowing cells to exclude 
the excess of protons and to recover their initial pH. Because of its relatively alkaline pH; 
dependence, the Na+-H+ exchange system of most excitable cells catalyzes a significant uptake 
of Na+ at a physiological pH; value. The Na+ -H+ exchange system may or may not be 
involved in volume regulation, depending on the cell type. In human red blood cells, the Na+ -
H+ exchange system is activated in response to exposure to hyperosmolar solutions and 
contributes to volume regulation. Activation of Na+-H+ exchange has also been proposed to 
be a signal of cellular differentiation. The activity of the exchanger appears to be modulated 
by several important biological agents, including hormones, growth factors, and tumor-
promoting agents (1). Na+ -H+ exchange may provide a mechanism for raising blood pressure 
by increasing intracellular Na+ concentratio_n or pH resulting in hypertension (2). The mean 
rate of Na+ -H+ exchange in red blood cells (RBCs) from hypertensive patients is higher than 
the mean rate measured in RBCs from normotensive controls (3). 
Lifton et al. (4) have cloned a gene encoding a RBC membrane protein effecting 
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amiloride-sensitive Na+ -H+ exchange. They mapped the gene locus to the short arm of 
chromosome 1 (1 p). 
Amiloride, which is an inhibitor of Na+-H+ exchange, blocked about 60% of Na+ 
transport when there was a pH gradient, but showed small inhibitory effects in the absence of 
pH gradients (5). This Na+ -H+ transport pathway was also sensitive to the amiloride analog 
5-N-methyl-N-butyl-amiloride (5). In the absence of Na+ gradient, an outward H+ gradient 
can drive a net amiloride-sensitive Na+ uptake (5). Intracellular Ca2+ can also activate Na+ 
transport which was inhibited to 30-60% by amiloride (6). At the condition of abolished 
proton gradient (pHin =pHou1) across the membrane, isosmotic and hyperosmotic media also 
stimulate Na+ -H+ exchange (7). The stoichiometry of Na+ and H+ fluxes by the Na+ -H+ 
exchanger suggests a 1:1 coupling of Na+:H+ fluxes over wide ranges of Na+ and proton 
concentrations (1). The activation of net transport by Na+ in the extracellular solution suggests 
that only a single binding site may be kinetically resolved (1). The internal H+ stimulates the 
net influx of Na+ with sigmoidal kinetics. Aronson et al. (8) proposed that the action of a 
modifier site alters the kinetics of activation because the dependence of net flux on internal 
[H+] had a slope which was greater than 1, suggesting kinetics with an order larger than first 
order. The kinetic information on Na+-H+ exchange suggest two possible models: one model 
is a random-binding simultaneous model, and this varies between cell types; another hypothesis 
is a modifier site on the cell membrane (1). 
Amiloride-sensitive Na+ -H+ transport is activated by cytoplasmic lithium (9). The flux 
due to external u+ has a stoichiometry of 1:1 and is sensitive to amiloride (9). Amiloride acts 
as a competitive inhibitor vs external u+ and Na+ acts as a competitive inhibitor of net Li+ 
influx. Conversely, external Li+ acts as a competitive inhibitor of net Na+ influx (10). All 
the information suggests that Na+, u+ and amiloride share a single external transport site. 
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Canessa et al. (11) investigated the kinetic effects of internal and external pH on Na+ -
H+, Li+-H+ and Na+-u+ exchange. These three exchange modes have highly asymmetric 
affinities H+ > >Li+> Na+. They are activated by internal H+ with a high "Hill coefficient" 
(n=2.5), and are competitively inhibited by external H+. Cell Li+ activated Na+-H+ exchange 
and was transported by Na+ -Li+ exchange at a lower rate than internal H+ (11). 
2. Na+-u+ Exchange in RBC 
The Na+-u+ ion exchange transport pathway in RBCs refers to the exchange of 
intracellular Li+ in Li+ -loaded RBCs with Na+ present in the plasma or in the suspension 
medium. Canessa et al. (12) found that treated or untreated hypertensive patients had a 
significantly higher rate of RBC Na+ -Li+ exchange than normotensive individuals. The rate 
of RBC Na+-Li+ exchange is consistently higher in hypertensives and in normotensives having 
a family history of hypertension than in normotensives who have no family history of 
hypertension (13). An autosomal gene locus encodes a polypeptide chain of the Na+ -Li+ 
exchange protein (14). This gene has not been mapped but it is known that it is located at one 
of the 22 pairs of nonsex autosomal chromosomes of the total 23 pairs of human chromosomes. 
The kinetics of Na+ -Li+ exchange or countertransport in human RBCs was studied 
(15, 16). A "ping-pong" model was proposed for the mechanism of Na+ -Li+ countertransport 
in RBC. The intracellular Na+ or Li+ (Na\ or Li+) bound to a carrier or an active site on the 
inner side of cell membrane was translocated to the outer side of cell membrane and then 
released to the outside of the membrane. The ion translocation through the membrane was the 
rate-limiting step. There are other Li+ pathways in RBC, such as the leak pathway, the 
ouabain-sensitive sodium pump, and the chloride-dependent Na+ -K+ cotransport system. All 
of these transport pathways are also used by the Na+ ion. The Li+ ion can also enter the RBC 
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by the band 3 protein; this transport pathway is, however, not shared by Na+ (17). 
Na+ -Li+ countertransport rates in RBCs from essential hypertensive patients are higher 
than in RBCs from normotensive controls (18-20). Because Na+ -H+ exchange also has higher 
mean rates in hypertensive patients than in normotensive controls, and the Na+ -H+ exchange 
is significantly correlated with Na+-u+ exchange (21), an important question arises. Are these 
two transport pathways mediated via the same transport protein or not? 
3. The Importance of Na+-H+ and Na+-Li+ Exchange in Hypertension 
When a person has diastolic blood pressure higher than 90 mmHg, he or she is 
considered to be hypertensive. When there is no any other medical cause for high blood 
pressure, the condition is defined as essential hypertension; otherwise it is referred to as 
secondary hypertension. The Na+ -H+ transport rate is defined as the Na+ influx in acid-loaded 
RBC suspensions at two different pH values. Study of hypertensive patients with insulin 
dependent diabetes mellitus (IDDM) showed that Na+ -H+ exchange and Na+ -Li+ exchange were 
significantly correlated in hypertensive, normotensive diabetics and controls (3). Na+ -H+ 
exchange rates were 78±28 mmol/L cell/hr in hypertensive IDDM, 50±21 in normotensive 
IDDM, and 55±24 in controls. Lt-Na+ exchange rates were 0.37±0.13 mmol/L cell/hr in 
hypertensive IDDM, 0.27±0.10 in normotensive IDDM, 0.25±0.11 in controls (3). These 
studies suggested that Na+ -H+ and Na+-u+ transport may be operated by the same exchange 
protein in the RBC membrane. Evidence exists, however, that Na+-H+ and Na+-u+ transport 
may be effected by different proteins. Amiloride is an inhibitor of human RBC Na+ -H+ 
exchange (5,6), but not of Na+-u+ exchange (22). A study of Na+ -Li+ countertransport with 
aging erythrocytes showed that the transport rate increased with aging blood; this increase was 
due to a phloretin insensitive component not present in young erythrocytes (23). The increase 
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of Na+ -Li+ countertransport rate in essential hypertensive patients was mainly due to an 
increased phloretin sensitive component. Amiloride had no effect upon Na+-Li+ exchange in 
cells of any age (23). Amiloride inhibited Na+ -H + exchange for rabbit RBCs and brush border 
vesicles (24,25). In contrast, amiloride inhibited both Na+ -H+ and Na+ -Li+ exchange in bovine 
vascular smooth muscle (26). Whereas Na+ -Li+ exchange is readily observable in human RBC 
at physiological conditions (12,27), Na+ -H+ exchange can only be activated under special 
conditions, such as acid loading or calcium activation (5,6), suggesting that the Na+ -Li+ 
countertransport was not a mode of action of the Na+ -H+ exchange in RBCs. 
Na+ -Li+ exchange rates were lower in RBC from manic-depressive patients receiving 
lithium carbonate than in normal individuals (17, 28). Na+-H+ exchange rates have not been 
measured in RBCs from manic-depressive patients, and it is not known what is the 
involvement, if any, of Na+ -H+ exchange in the etiology of manic-depression. 
Based on these arguments, a molecular level study of Na+-H+ and Na+ -Li+ exchange 
pathways in human RBCs is required to decide whether these two transport mechanisms occur 
via the same membrane protein or not. 
4. Techniques for Measurement of Metal Ion Transport 
Measurements of Na+ -Li+ countertransport in human RBC suspensions have been 
obtained using NMR and atomic absorption (AA) methods. The rate of Na+-Li+ exchange 
determined using a special NMR method, a modified inversion recovery (MIR) pulse sequence, 
was significantly correlated with the measurements made by AA (28,29). The rate of Na+-
Li+ exchange for 10 hypertensive patients (0.53 ±0.02 mmol/L cell/hr) was significantly higher 
than the mean rates for 10 matched normal controls (0.22±0.02 mmol/L cell/hr) (29). Similar 
NMR and AA measurements were obtained for psychiatric patients receiving lithium carbonate 
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and normal controls (28); that study showed that the rates of Na+ -Li+ countertransport from 
14 psychiatric patients on lithium therapy were significantly lower than the rates from 14 
normal controls (0.12±0.03 mmol/L cell/hr for patients and 0.22±0.03 mmol/L cell/hr for 
controls). 
Lanthanide shift reagents have been used to distinguish the intra- and extracellular pools 
of alkali-metal ions (30-34). Dy(PPP)21- gives larger upfield chemical shifts than the downfield 
shifts induced by Dy(TfHAt. Whereas the alkali metal NMR shifts afforded by Dy(PPP)27-
are dependent on pH and subject to competition by other metal cations, those afforded by 
Dy(TfHA)3- are not (35). Because of its high negative charge, the shift reagent Dy(PPP)21-
increases the ionic transport rates and changes the transmembrane ion distribution and 
membrane potential (32,33). The u+ transport rates measured in the presence of Dy(PPP)21-
by 7Li NMR or AA were higher than those measured in the presence of Dy(ITHA)3- or in the 
absence of shift reagents; the Li+ RBC transmembrane ratios ([Li+]Recl[Li+]p1aama) measured in 
the presence of triphosphate shift reagent were higher than those measured in the two other 
suspension media under the same conditions (32,33). These effects are related to the mode of 
binding of alkali metal cations to Dy(PPP)21- (31). Shift reagents with a lower negative charge 
such as Dy(TfHAt do not affect the u+ transport rate and membrane potential (32,33). 
Studies on 7Li relaxation time measurements of Li+ -loaded RBCs have been conducted 
(36,37). The spin-lattice relaxation time (f1) of 7Li in u+ -loaded RBCs with approximately 
1.5 mM intracellular u+ concentration was significantly longer (5.6±0.4 s) than the spin-spin 
relaxation time (f2) (0.09±0.02 s) (n=3). u+-loaded ghosts with 1.5 mM u+ concentration 
also have longer T1 (11.1±0.90 s) than T2 values (0.17±0.02 s) (n=3). Slow motions 
contribute only to T2, whereas components of motion at the resonance frequency contribute to 
both T1 and T2 (38). The relaxation times for a 1.5 mM LiCl aqueous solution whose viscosity 
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was adjusted to that of intracellular RBC (5 cP) with glycerol were 1.0±0.1 s for T 1 and 
0.8±0.1 s for T2 (36,37). Thus, the high intracellular viscosity decreased both T1 and T2 
values but was not responsible for the difference between T1 and T2 values observed in Li+ -
loaded RBCs. Because the same relaxation behavior was observed in RBC ghosts and intact 
RBCs, this difference between T1 and T2 for intracellular u+ was attributed to the binding of 
Li+ to the RBC membrane. This proves that Li+ binds to the RBC membrane and 7Li NMR 
relaxation times are a good probe to detect Li+ binding information to the RBC membrane. 
Canessa, M. (39) studied Na+ -H+ transport in RBC using AA. The transport rates had 
large interindividual differences in red cells of normal subjects (10-40 mmol/L cell/hr). 23Na 
NMR studies on Na+ binding to human RBC membrane were conducted by several groups (40-
42). Evidence for K+ competition with Na+ binding sites on erythrocyte membrane was 
demonstrated by a decrease of the sodium line width in the presence of K+ (40). The NMR 
longitudinal relaxation rate (l/T1) of 23Na was studied on unsealed human RBC ghosts from 
hypertensive patients and normotensive controls in the presence and absence of ouabain 
(41,42). Na+ had tighter binding with normotensives and weaker binding with hypertensives; 
using James-Noggle plots, hypertensives gave binding constants of the order of 100 M-1 (n = 2) 
and normotensives had relatively higher binding constants in the range of 500-1000 M-1 (n=7). 
By adding 5 mM ouabain, which is an inhibitor for (Na++ K+)-ATPase, the 23Na T1 was 
increased and the binding constant was about 2000 M-1 (42). At lower [Na+] ranges, Na+ 
binds to the membrane protein (Na++ K+)-ATPase. As [Na+] increases ( > 5 mM), Na+ started 
to bind to other membrane proteins combined with lipids (41). 
The NMR visibility of intracellular Na+ in RBC is about 80% (43), whereas that of 
intracellular u+ is 100% (32). Therefore, the visibility factor of 0.8 must be taken into 
account in the Na+ transport measurements by 23Na NMR of human RBC suspensions. 
CHAPTER II 
STATEMENT OF THE PROBLEM 
The primary goal of this project is to study the binding of Na+ and u+ ions to human 
RBC membrane using nuclear magnetic resonance relaxation methods to advance the 
understanding of Na+-H+ and Na+-u+ transport in human RBCs. 
AA studies of Na+ -Li+ transport in human RBC suspensions were previous} y performed 
(18,28,29,39). Also AA measurements of Na+ -H+ transport in human RBC suspensions have 
been conducted (39). A shortfall of the AA method is that separation of cells from the 
suspension medium and lysis of the intracellular compartment is required prior to AA analysis. 
An ionic concentration adjustment during sample processing could occur. The initial ion 
transport information may also be lost under these conditions. In addition to being invasive, 
these techniques are time consuming. The AA method loses vital information on ion binding 
to membrane, the nature of ion binding sites, and changes in membrane potential. 
The NMR method used in this study enables detection of Na+ and u+ concentrations 
and pH changes while transport occurs. The NMR measurements are performed on the same 
blood sample without interrupting ion transport. Concentrations and pH values are obtained 
from intact viable cells. The NMR relaxation measurements provide a detailed molecular 
understanding of the factors that control the rates of transmembrane ion transport. Such an 
NMR investigation of the Na+ -H+ transport pathway in human RBCs had never been conducted 
before. 
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1. Characterization of the Na+ and Li+ Binding Sites in Human RBC Membranes 
According to Canessa's work (11), the three ions of interest H+, u+ and Na+ have the 
following relative affinities in red blood cells: H+ > > u+ >Na+, and the interaction of these 
ions with the two sides of the RBC membrane is asymmetric. I propose to study the ion 
competition mechanism using 7Li and 23Na NMR measurements of human RBC membrane 
samples at different pH values. 
2. Characterization of the Effect of Inhibitors on Ion Transport 
Previous studies showed that amiloride, which is an inhibitor for Na+ -H+ transport, had 
no effect on Na+ -Li+ countertransport (22) and phloretin, which is an inhibitor for Na+ -Li+ 
exchange, had no effect on Na+-H+ transport (23). Inhibition effects may not show up in ion 
transport assays because of their low sensitivity. A NMR relaxation time study was designed 
to study the competition between metal ions and inhibitors for the human RBC membrane. 
3. Na+ -H+ Transport in Human RBCs by 23Na and 31P NMR 
I propose to use 23Na NMR spectroscopy to monitor Na+ flux through the Na+-H+ 
exchange pathway in human RBC suspensions by using the shift reagent Dy(TIHAY3". 
The indicator methylphosphonate (MeP) was used to monitor intracellular pH (44-46). 
I propose to use MeP to detect pH changes during the course of Na+ -H+ exchange in human 
RBC suspensions. 
1. Materials 
1.1. Reagents 
CHAPTER III 
MATERIALS AND METHODS 
Lithium chloride (LiCl), dysprosium chloride (DyCl3), triethylenetetraamine hexacetic 
acid (TIRA), deuterium oxide (99.8% D20), sucrose, sodium chloride (NaCl), potassium 
chloride (KCl), magnesium chloride (MgClJ, choline chloride and methyl sulfoxide (DMSO) 
were supplied by Aldrich (Wisconsin). HEPES [4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid], Tris-(hydroxymethyl)aminomethane (Tris), bumetanide, amiloride, ouabain, MES (2-
[N-morpholino]ethanesulfonic acid), MOPS (3-[N-morpholino]propanesulfonic acid), DIDS 
(4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid), nystatin, phloretin and albumin (bovine 
fraction V) were supplied by Sigma Chemical Company (St. Louis, MO). Methazolamide was 
supplied by Lederle Laboratories Division of the American Cyanamide Company (Pearl River, 
NY). n-butyl phthalate from Fisher Scientific Company (Fairlawn, NJ). Methylphosphonic 
acid was from Alfa Products (Ward Hill, MA). All chemicals were used as received. 
1.2. Blood samples 
Fresh red blood cells were supplied by the Chicago Chapter of Life Source. Blood 
samples from hypertensive patients were obtained through Loyola University Medical Center. 
The protocols for experiments involving human blood were approved by the Institutional 
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Review Board for the Protection of Human Subjects (Loyola University Medical Center). 
2. Sample Preparation 
2.1. Preparation of acid-loaded RBCs (39) 
The intracellular pH of 5.8 in RBCs was reached by incubating the cells at 10% Ht in 
acid-loading solution (170 mM KCl, 40 mM sucrose, 10 mM glucose, 20 mM Tris-MES 
buffer, pH=5.6, 0.1 mM ouabain, 0.01 mM bumetanide, 0.15 mM MgC12, 350 mOsm) for 
10 minutes in a 37 °C water bath. I then added 1.0 ml of acid-loading solution containing 
DIDS and methazolamide to lock the cell pH. The final concentration of DIDS was 0.2 mM 
and methazolamide was 0.5 mM. The cell suspensions were kept at 37 °C for an additional 
30 minutes. These acid-loaded cells were washed at 4 °C four times with 5 volumes of acid-
washing solution (170 mM KCl, 40 mM sucrose, 0.15 mM MgCl2). 
The intracellular pH was checked by lysing 0.2 ml of packed RBCs in 2 ml of double 
distilled water allowing 5 minutes to reach equilibrium. The acid-loading solution was made 
fresh and I checked the pH before cell loading. The inhibitors were made fresh daily and 
added to acid-loading solutions before cell loading. 
2.2. Preparation of sodium-modified RBCs (39) 
Nystatin, a channel-forming ionophore, was used to bring cell sodium concentration 
to the desired level. One volume of washed packed RBCs was added at 4 °C to five volumes 
of nystatin containing solutions (150 mM KCl, 40 mM sucrose, 40 µglml nystatin for removing 
cell sodium, or 150 mM NaCl, 40 mM sucrose, 40 µglml nystatin for increasing cell sodium) 
and kept in the dark at 4 °C for 20 minutes. The suspension was then replaced by loading 
solution without nystatin and incubated at 4 °C for another 10 minutes. Nystatin was removed 
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by adding 5 volumes of nystatin washing solution (150 mM KCl, 40 mM sucrose, 10 mM 
glucose, 10 mM potassium phosphate buffer, pH=7.4, lg/liter albumin) to the cells. The cells 
were incubated at 37 cc for 10 minutes. After four times washing with nystatin washing 
solution, nystatin was completely removed. Final cell sodium concentration was checked by 
atomic absorption or NMR spectroscopy. Nystatin must be added fresh daily. 
2.3. Preparation of lithium-loaded RBCs (18) 
Washed RBCs were added to lithium loading solution (150 mM LiCl, 20 mM glucose, 
20 mM Tris-MES buffer, pH=7.4) at 10% Ht and incubated at 37 cc for 3 hours. Cells were 
washed four times by choline washing solution (112 mM choline chloride, 85 mM sucrose, 10 
mM glucose, 10 mM Tris-MES buffer, pH=7.4). The final cell lithium concentration was 
determined by atomic absorption. 
2.4. Preparation of CO and deoxy RBC 
The CO form of RBC was prepared by bubbling washed RBC with CO gas for 30 
minutes. The deoxy form of RBC was prepared by bubbling RBC with N2 gas for 30 minutes. 
These gas bubbled RBCs were used within half an hour after preparation, and were 
characterized using 31P NMR spectroscopy (44,45). 
2.5. Preparation of RBC membrane (47) 
Blood was washed by 5 volumes of PBS (150 mM NaCl, 5 mM KP04) three times at 
6,686 g for 5 minutes. Packed washed RBCs were then lysed by 5H8 (5 mM HEPES-
Tetramethylammonium hydroxide pentahydrate, pH=8.0) at a ratio of approximately 1:40 but 
not higher than 1 :20. The lysate was centrifuged at 26, 746 g for 10 minutes. The supernatant 
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was aspirated and the remaining membrane was washed two more times until cloudy white. 
2.6. Preparation of shift reagent (48) 
Dysprosium (III) triethylenetetraamine hexacetate (DyTIHA3-) was prepared from 
dysprosium hydroxide and H6TIHA. For preparing 5 ml of 0.125 M stock solution of 
N~DyTIHA, 0.2356 g of DyCl3 was first dissolved in 3 ml water. H6TIHA powder (0.3090 
g) was then dissolved in DyC13 • I titrated 1.5 ml of 2.5 M NaOH in 30 µl aliquots while 
stirring. The final pH was less than 8.0 and the solution was clear. To exclude sodium from 
the shift reagent preparation, tetramethylammonium hydroxide was used to titrate instead of 
sodium hydroxide. 
2.7. Membrane digestion for protein concentration analysis (49) 
Membrane made from RBC was diluted four times to fit into a standard curve. The 
Bradford stock solution was purchased from Bio-Rad. The working buffer (425 ml distilled 
water, 15 ml 95% ethanol, 30 ml 88% phosphoric acid, 30 ml Bradford stock solution) which 
was used to digest membrane was also added to the blank. 
3. Instrumentation 
3.1. NMR spectrometer 
23Na, 7Li and 31 P measurements were made at 79.4, 116.5 and 121.4 MHz respectively 
on a Varian VXR-300 NMR spectrometer. The instrument was equipped with a 10 mm 
multinuclear probe and a variable temperature unit. All blood and membrane samples were 
used at 37 °C. Packed Na+ modified cells were put into 10 mm NMR tubes to measure T1 
and T2 values without spining, whereas membrane samples were studied spining. Field-
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frequency locking and shimming on D20 present in the aqueous media was done spining every 
time before blood sample measurements. 
For Na+-H+ transport measurements, each 23Na spectrum was obtained with 200 
transients, with a 60° degree pulse width (19 µs for the 10 mm low frequency probe; 22 µs 
for the 10 mm high frequency probe) and line broading of 2 Hz. Each 31 P spectrum was 
obtained with 1,200 transients, a 60° degree pulse width (13 µs) and line broading of 1 Hz. 
A standard single pulse sequence was employed to obtain the NMR spectra of transport 
measurements. Spin-lattice relaxation time (T1) measurements were performed using the 
inversion recovery method; spin-spin relaxation time (T J measurements were done by the Carl-
Purcell-Meiboom-Gill method (38). The pulse sequences used for the NMR measurements are 
shown in Figure 1. 
3.2. Atomic absorption spectrophotometer 
AA studies were performed on a Perkin-Elmer spectrophotometer, model 5000, 
equipped with a graphite furnace. 
3.3. UV-Visible spectrophotometer 
UV-Visible studies were conducted on an IBM Instruments Inc. spectrophotometer, 
model 9420. Hemoglobin and protein concentration measurements were conducted using 
Method 2 (single wavelength measurement). Hemoglobin concentration was measured at 415 
nm (50) and protein concentration at 595 nm (49). For hemoglobin concentration 
measurements, I used double distilled water as a blank, whereas the blank for protein 
concentration measurement was the Bradford reagent plus 5H8. 
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Figure 1: NMR pulse sequences for standard and T, and T2 measurements. (A) Standard 
single pulse sequence. (B) Inversion recovery pulse sequence for T, measurements. (C) Carl-
Purcell-Meiboom-Gill pulse sequence for T2 measurements. AT is the acquisition time. PW 
is the pulse width (it can be 90°, 60° or 45°) in the standard single pulse sequence. P, is the 
180° pulse width, and D, and D2 are the delay times between the radiofrequency pulses. 
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3.4. Osmometer 
The osmolarity of the suspension medium for all the RBC samples was checked by a 
Wescor Vapor Pressure Osmometer (Wescor Inc., Logan, UT) and adjusted to 300+ 10 mOsm 
with sucrose. The osmometer was checked every month with a 290 mOsm standard solution. 
3.5. Centrifuge 
Blood processing and unsealed membrane were prepared at 4 °C using a Beckman J2-
2 l refrigerated centrifuge equipped with the fixed angle rotors JA-10 and JA-20. A Savant 
refrigerated centrifuge, model HSC 10000, was also used for washing and separating RBCs. 
4. Data Analysis 
4.1. Na+ -H+ transport by atomic absorption (39) 
Acid loaded cells (pHin around 5.7) were added to Na+ influx suspension media at 
pH=6.0 or at pH=8.0 (150 mM NaCl, 10 mM glucose, 10 mM buffer, Tris-MES for pH 6 
or Tris-MOPS for pH=8.0, 0.15 mM MgC12, 0.1 mM ouabain, 0.01 mM bumetanide, around 
350 mOsm, ouabain and bumetanide made fresh daily). Transport experiments were conducted 
at 37 °C and 2 % hematocrit. For pH 6.0, 250 µl duplicates were taken at 1 and 20 minutes. 
For pH 8.0, 250 µl duplicates were taken at 1, 5 and 11 minutes. These samples were pipetted 
into prechilled 1 ml centrifuge tubes containing 0.6 ml sodium free solution (80 mM choline 
chloride, 82 mM KCl, 0.25 mM MgC12, 10 mM Tris-MOPS buffer, pH 7.4) and 0.3 ml 
dibutyl phthalate. The samples were spun at 10,519 g for 1 minute. The solution and oil were 
aspirated and the top part of the tube was wiped to avoid sodium contamination. Double 
distilled water (1 ml) was added to the tube to lyse the packed red blood cells. These tubes 
were kept in the refrigerator overnight at 4 °C. Before optical density and AA measurements, 
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cell lysates were centrifuged for 10 minutes at 2,078 g to lyse the remaining cells. Cell lysate 
(40 µl) was added to 3.96 ml double distilled water and the optical density representing 
hemoglobin concentration was measured by UV-visible spectroscopy at 415 nm. A standard 
was made by pipetting 500 µl packed red blood cells to 9 .5 ml choline wash solution to 
measure the hematocrit. Twenty µl of this solution was added to 2 ml of water to measure the 
optical density. The cell sodium concentration was calculated using the equation (39): 
[Na] (mmol/L)= [Na]1y1(µM) xOD.land/(Ht,land xOD1y1lOOO), (1) 
where [Na]1y1 and OD1y1 were the sodium concentration and optical density of cell lysate 
measured by AA and UV-Visible, respectively, and Ht.land and OD.land were the hematocrit and 
optical density of the standard sample, respectively. 
The Na+ -H+ transport rate was obtained by subtracting the sodium influx rate at pH 
6.0 from that at pH 8.0. 
4.2. Na+ -Li+ transport by atomic absorption (18) 
Li+ loaded red blood cells (600 µl) were added to 5.4 ml NaCl suspension (150 mM 
NaCl, 10 mM glucose, 10 mM buffer pH 7.4, 0.1 mM ouabain) or to 5.4 ml choline chloride 
suspension (112.5 mM choline chloride, 10 mM glucose, 10 mM buffer pH=7.4, 0.1 mM 
ouabain). At 15, 30, 45, 60 and 75 minutes, 1 ml aliquots were taken from either the NaCl 
or the choline suspensions and centrifuged at 10,519 g for 2 minutes. Supernatants were kept 
to measure lithium concentration. The Na+ -Li+ transport rate was obtained from the equation 
shown below: 
Rate= Slop~.c1 X (l-H~.ci)/HtN.c1-SlopeChouno X (1-H~lino)/HtCholino (2) 
4.3. Na+ -H+ transport by DNa and 31P NMR 
Na+ influx 
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Acid loaded RBCs were added to Na+ influx suspensions at pH 6.0 or at pH 8.0 (129 
mM NaCl, 7 mM N~DyTIHA, 0.15 mM MgCl2, 10 mM glucose, 10 mM buffer, Tris-MES 
for pH 6.0 or Tris-MOPS for pH 8.0, 0.1 mM ouabain, 0.01 mM bumetanide). The 23Na 
NMR measurements were taken immediately after mixing cells with suspensions at 20% Ht. 
All RBC samples were run unlocked and without spining to avoid cell settling. The 23Na 
spectra were the average of 5 minute acquisitions with 5 minute intervals up to an hour. 
The intracellular Na+ concentration was obtained from the equation shown below: 
(3) 
where [Na+]ilil is the intracellular Na+ concentration at time 0 minute, obtained from AA 
measurements of packed, acid-loaded RBCs, [Na+]OUI() is the starting concentration of Na+ in 
the suspension, R is the ratio of peak areas for intracellular and extracellular 23Na+ NMR 
resonances during the course of the transport experiment. The visibility factor for the 
intracellular Na+ NMR resonance, 0.8, was taken into account in the calculation (43). 
Na+ efflux 
Na+ loaded RBCs were added to efflux suspensions at pH 6.0 or at pH 8.0 (129 mM 
KCl, 7 mM DyTIHA3 in tetramethylammonium form, 0.15 mM MgC12, 10 mM glucose, 10 
mM buffer, Tris-MES for pH 6.0 or Tris-MOPS for pH 8.0, 0.1 mM ouabain, 0.01 mM 
bumetanide). The 23Na NMR measurements were the same for Na+ influx. The intracellular 
Na+ concentration was calculated from the equation shown below: 
(4) 
where the symbols have the same meaning as for equation (3). The derivation of equations (3) 
and (4) is given in Appendices I and II. 
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u+ transport (45) 
The intracellular pH indicator methyl phosphonate (MeP) was loaded into the RBCs 
at the beginning of acid loading by incorporating 10 mM MeP in the acid loading solution. 
These acic-loaded and MeP-loaded RBCs were added to Na+ influx suspensions at pH 6.0 or 
at pH 8.0. The 31P NMR measurements were taken from packed RBCs at O min and 30 min 
for both pH 6.0 and pH 8.0. 
CHAPTER IV 
RESULTS 
1. 23Na NMR Relaxation Time Measurements of Intact RBCs 
23Na NMR relaxation times are a weighted average of the relaxation times of free and 
bound Na+. If competition occurs among H+, u+ and Na+ for binding to the RBC membrane 
transport protein, by increasing [H +] and [Ln the amount of free Na+ should increase causing 
the relaxation times of 23Na to increase. 
Packed RBCs were loaded at different pHin values, and 23Na relaxation times were 
measured (Figure 2, Table 1). A small difference in relaxation times existed between the two 
blood samples studied. The different protein concentrations in RBC membranes or the different 
intracellular Na+ concentrations may be responsible for the small differences in relaxation 
times. For both blood samples, the T2 values (Figure 2B) were significantly shorter than the 
T1 values (Figure 2A), indicating that 23Na NMR relaxation mesurements are sensitive to Na+ 
binding in RBCs. 
As expected, by decreasing pHin H+ competed with Na+ for binding sites in RBCs. 
More free Na+ resulted in higher 23Na relaxation times. Since [Na+]in did not change markedly 
within each experiment, the observed changes in relaxation times were due to different 
redistributions of Na+ ions between bound and free forms in the two blood samples. From the 
data above, one might conclude that intracellular Na+ concentration may change the 23Na NMR 
relaxation values. Further studies of the effect of intracellular Na+ concentration on 23N a NMR 
21 
22 
Figure 2. pH dependence of 23Na NMR relaxation times in intact RBCs. (A) 23Na T1 
relaxation times vs cell pH. (B) 23Na T2 relaxation times vs cell pH. Packed RBCs were 
loaded at different pH;,, values by conducting acid loading in suspension media of various pH 
values (see Methods). The relaxation time measurements were made in packed RBCs without 
spining. Only the values for the first blood sample (Table 1) are plotted. 
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Table 1. Dependence of 23Na NMR relaxation times on intracellular pH. Same conditions as 
for Figure 2. 
pH T/ms T2/ms [Na+];)mM 
First blood sample 
5.56 39.0± 1.0 17.1±0.3 10.8 
5.58 38.9± 1.0 15.5±0.4 10.5 
5.77 37.1±1.0 15.1±0.1 12.8 
5.77 36.4±0.7 15.6±0.5 12.5 
6.15 34.1±0.5 14.1±0.4 13.2 
6.18 34.4± 1.0 14.1±0.2 10.4 
6.63 31.6±0.1 12.9±0.3 12.0 
6.63 32.2±0.3 11.7±0.4 12.0 
6.68 30.4±0.7 12.3±0.2 11.0 
6.99 29.7±0.5 11.8±0.2 11.8 
Second blood sample 
5.58 36.3±2.0 16.8±0.7 6.18 
5.76 36.6±1.0 16.8±0.5 6.23 
5.97 33.4± 1.0 13.7±0.4 5.98 
5.83 35.1±1.0 14.6±0.6 6.67 
6.21 33.0±0.7 13.0±0.9 5.16 
6.59 30.4±0.8 13.3±0.4 6.72 
6.76 29.1±0.6 11.2±0.3 6.49 
6.71 28.0±0.2 9.77±0.4 7.67 
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relaxation times (Figure 3, Table 2) show that in a very large intracellular Na+ concentration 
range, the relaxation times did not change significantly with Na+ concentration. However, the 
relaxation times differed at two different intracellular pH values (7.4 and 5.8). In the Na+ 
concentration range from 1 mM to 22 mM, the relaxation times were higher in pH 5. 8 cells 
than in pH 7.4 cells as shown before. Because the physiologic intracellular Na+ concentration 
is between 6 mM and 10 mM (51), 23Na NMR relaxation times are sensitive to competition 
between Na+ and H+ for binding sites in RBC for physiologically relevant intracellular Na+ 
concentration and pH values. 
By changing cell pH, hemoglobin will have a different distribution between deoxy and 
oxy forms due to the Bohr effect (52). The deoxy form of hemoglobin has a paramagnetic 
center (high spin Fe2+) which may cause the 23Na+ NMR resonance to broaden and give a 
lower relaxation time. The 23Na NMR relaxation times of RBCs in three different oxygenated 
forms were measured (Table 3). The N2 bubbled RBCs have predominantely the deoxy form 
of hemoglobin; the CO bubbled RBCs provide a more stable analog of the oxy form. The 23Na 
NMR relaxation times did not change appreciably in the three forms. Thus, the pH-induced 
changes in 23Na relaxation times reported above are not caused by the magnetic properties of 
hemoglobin. The 31P NMR spectra of these cells were taken to insure accuracy of preparation 
(Figure 4, Table 4). The N2 bubbled RBCs which have the paramagnetic hemoglobin center 
have all 31P peaks broadened and subject to downfield chemical shifts (45). The CO bubbled 
RBCs are diamagnetic with sharp and upfield 31P NMR resonances (45). 
2. ~Na and 7Li NMR Relaxation Time Measurements of Unsealed Membrane 
2.1. Dependence of ~Na NMR relaxation time values on sodium concentration 
The protein which operates Na+ -H+ transport is located in the RBC membrane, making 
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Figure 3. Dependence of 23Na NMR relaxation times on intracellular sodium concentration in 
packed sodium-modified RBCs. The Na+ modified RBCs were prepared using nystatin (see 
Methods). For pH 5.8 cells, the RBCs were loaded in the acid-loading solution (see Methods) 
after nystatin treatment. In (A) the stars represent T, values, whereas the diamond symbols 
denote T2 measurements for an intracellular pH of 7.4. In (B) the stars represent T, whereas 
the diamonds show T2 values for pH 5.8 cells. 
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Table 2. Dependence of 23Na NMR relaxation times on intracellular sodium concentration in 
packed sodium-modified RBCs. Same conditions as for Figure 3. n= 1. 
T/ms T/ms 
A) pHm=7.4 
1.6 29.9±0.5 9.5±0.3 
2.2 30.3±0.6 10.8±0.6 
2.6 31.1±1.0 10.8±0.4 
8.9 30.1±0.7 10.5±0.4 
14.4 30.1±0.5 10.5±0.5 
21.5 32.1 ±0.7 11.3±0.6 
B) pHm=5.8 
1.2 37.4±2.0 14.4±0.7 
2.5 39.5±2.0 15.6±0.3 
4.0 43.2±3.0 14.0±0.3 
8.5 40.0±2.0 20.5± 1.0 
12.7 41.0±4.0 15.8±0.9 
20.3 35.4±0.2 15.2±0.2 
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Table 3. 23Na NMR relaxation times of packed intact RBCs in various oxygenation states. 
T/ms 
RBC 30.1±0.3 11.3±0.6 11.4 6.75 
30.1±0.5 11.8±0.6 11.4 6.72 
N2 RBC 33.0±1.0 10.8±0.6 12.1 6.75 
31.4±0.7 12.2±0.5 12.1 6.74 
CORBC 29.1±0.2 10.0±1.0 11.8 6.75 
30.7±0.3 10.7±0.7 11.8 6.72 
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Figure 4. 31P NMR spectra of packed RBCs in various oxygenation states. (A) CO bubbled, 
packed RBCs. (B) Packed RBCs. (C) N2 bubbled, packed RBCs. 
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Table 4. 31P NMR chemical shifts and linewidths for RBCs in different oxygenation states. 
Av112 is the linewidth at half height for the a, (3 and 'Y phosphate resonances of ATP, oPi-P is the 
chemical shift separation between the Pi and the (3 phosphate resonances of ATP. 
CORBC 
RBC 
N2 RBC 
21.023 
21.156 
21.551 
43.84 
39.49 
39.62 
36.81 
39.34 
43.10 
65.93 
53.35 
73.15 
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the cell membrane a likely binding site for Na+. A large number of Na+ binding sites are 
present in intact RBCs. To investigate the putative binding of Na+ to the Na+ -H+ exchange 
protein, a 23Na NMR relaxation study of purified RBC membrane was conducted. Unsealed 
RBC membranes were made from blood from Life Source (see Methods). The relaxation times 
increased as Na+ concentration increased at both pH 8.0 and pH 6.5 (Figure 5, Table 5). The 
number of binding sites for Na+ in the membrane samples was constant; with an increase in 
Na+ concentration, more free Na+ having a higher relaxation time existed leading to an 
increase in the observed relaxation times. 
2.2. Dependence of 2.1Na and 7Li relaxation time on pH of membrane preparation 
The binding sites in RBC membrane for Na+ have the relative affinity 
H+ > u+ > >Na+ (11). In membrane preparations with various pH values, the 7Li relaxation 
times increased as the pH of the membrane sample decreased (Figure 6, Table 6). All three 
samples show that when the pH of the membrane samples is increased, the 7Li T 1 values 
decrease. The T1 differences among samples may be caused by the different amount of 
membrane protein. The duplicates in sample 2 indicate that these measurements are 
reproducible with an intraindividual coefficient of variation of 13% (Table 6). As Na+ binds 
much more weakly than u+, the pH-induced changes of 23Na relaxation times were smaller 
than those observed for 7Li (Figure 7, Table 7). Both samples show that as the pH of the 
membrane samples decreased, the relaxation times increased. After adding u+ to the samples, 
the 23Na T1 increased further. The T1 values are different in the two samples. This may again 
be caused by different protein concentrations in the membrane samples (Table 7). By adding 
LiCl to the Na+ membrane samples, u+ replaced bound Na+ which resulted in higher 23Na T1 
values (Figure 7, Table 7). 
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Figure 5. Dependence of 23Na T1 values in unsealed membrane on Na+ concentration at pH 
8.0 (open squares) and pH 6.5 (diamonds). Unsealed membranes were made by 5H8 from 
blood from Life Source. Aliquots from a 0.5 M NaCl stock solution were added to 2.5 ml 
membrane to obtain the final Na+ concentration in the range 2 mM to 37 mM. Before NMR 
measurements, pH 6.5 membrane samples were treated with 10 mM Tris-MES buffer, 
pH=5.7. The pH of the membrane preparation was confirmed with a pH meter after 
relaxation time measurements. Each point is the average of three measurements. The protein 
concentrations of the membrane samples were 6.5±0.4 mg/ml for the pH 8.0 samples and 
6.4± 1.0 mg/ml for the pH 6.5 samples. 
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Table S. Dependence of 23Na T1 values in unsealed membrane on Na+ concentration. Same 
conditions as for Figure 5. n = 3. 
[Na+]/mM T/ms AVG 
A) pH=8.0 
2.0 36.4±2.0 37.7± 1.0 40.2±0.8 38.1±1.9 
4.0 38.3±0.3 39.7±1.0 44.9± 1.0 41.0±3.5 
8.0 43.0±0.6 43.2±0.7 46.9±0.7 44.4±2.2 
11.0 47.3±0.6 48.4±0.6 47.4±0.8 47.7±0.6 
16.0 48.1±0.5 50.6±0.7 50.5±0.4 49.7± 1.4 
22.0 51.8±0.7 52.7±0.5 52.1±0.4 52.2±0.5 
29.0 55.2±0.2 53.8±0.5 54.8±0.5 54.6±0.7 
37.0 55.6±0.4 55.8± 1.0 56.1 ±0.5 55.8±0.3 
B) pH=6.5 
2.0 45.1±6.0 42.2±1.0 43.2±2.0 43.5± 1.5 
4.0 44.3±2.0 46.9±2.0 47.1±2.0 46.1± 1.6 
8.0 49.2±0.3 47.5±0.7 46.2±0.7 47.6± 1.5 
11.0 47.7±0.4 47.4±0.7 47.3±0.8 47.5±0.2 
16.0 49.5±0.3 48.6±0.3 49.9±0.5 49.3±0.7 
22.0 51.8±0.4 51.1±0.4 50.9±0.5 51.3±0.5 
29.0 53.0±0.5 54.0±0.5 51.7±0.2 52.9± 1.2 
37.0 54.4±0.2 55.0±0.4 54.3±0.6 54.6±0.4 
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Figure 6. pH dependence of 7Li NMR relaxation times in membrane samples. Unsealed 
membranes were added to buffers of different pH at 10 mM concentration to obtain different 
pH values. The pH of each sample was confirmed after each relaxation time measurement. 
Sample 3 in Table 6 is plotted. 
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Table 6. pH dependence of 7Li NMR relaxation times in membrane samples. Four separately 
prepared membranes were used. Same conditions as for Figure 6. 
Membrane pH T/s [Protein ]/mg/ml 
Sample 1 
6.05 7.9±0.3 8.13 
6.49 8.1±0.4 6.80 
6.92 7.0±0.5 6.41 
7.30 6.6±0.6 6.13 
7.59 6.3±0.4 5.52 
8.01 4.5±0.3 6.46 
Sample 2 
7.71 9.2±0.5 8.4±0.7 7.25 7.37 
7.55 9.7±0.3 10.7±0.4 6.71 7.42 
7.08 12.0±0.7 9.9±0.8 6.79 7.21 
6.77 9.7±1.1 8.0±0.4 8.84 8.91 
6.13 13.0±1.0 12.2± 1.7 7.71 6.54 
Sample 3 
7.70 6.8±0.2 6.43 
7.58 6.2±0.5 5.79 
7.41 6.2±0.6 8.05 
7.37 6.5±0.5 6.95 
7.20 7.6±0.6 6.65 
7.15 8.6±0.4 7.35 
6.98 9.1±0.4 7.95 
6.89 9.4±0.3 8.15 
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Figure 7. pH dependence of 23Na NMR relaxation times in membrane samples. A 3 mM NaCl 
was added to each membrane sample to obtain the 23Na T1 values (stars). After these 
measurements, 3 mM LiCl were added to the same membrane samples and the 23Na T1 were 
remeasured (diamonds). Sample 2 in Table 7 is plotted here. 
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Table 7. pH dependence of 23Na NMR relaxation times in membrane samples. Two separately 
preparaed membranes were used. Same conditions as for Figure 7. 
Membrane pH T/ms (without Li+) [Protein ]/mg/ml 
Sample 1 
8.01 37±1 41±3 6.46 
7.59 41±3 43±2 5.52 
7.30 46±3 50±5 6.13 
6.92 45±1 47±5 6.41 
6.49 44±3 47±3 6.80 
6.05 49±4 45±2 8.13 
Sample 2 
7.70 42±2 55±2 6.43 
7.58 47±3 55±2 5.79 
7.41 40±3 51±3 8.05 
7.37 45±3 55±3 6.95 
7.20 51±1 50±3 6.65 
7.15 47±1 56±3 7.35 
6.98 48±4 53±3 7.95 
6.89 54±3 58±2 8.15 
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2.3. 23Na and 7Li NMR relaxation time measurements in the presence and absence 
of transport inhibitors 
Amiloride is an inhibitor of Na+-H+ transport (5) and phloretin is an inhibitor of Na+-
u+ transport (22). If the inhibitors bind to the RBC membrane transport protein, by adding 
inhibitors to Na+ - or u+-treated membranes, the 23Na and 7Li relaxation times should increase 
as the inhibitor concentration increase. As expected, amiloride caused increases on both 23Na 
(Figure 8, Table 8) and 7Li (Figure 9, Table 9) NMR relaxation times. The changes in T1 
values in Table 8 are smaller than the changes in Table 9, because Na+ binds more weakly to 
the membrane than Li+ (11). Amiloride could bind to Na+ or u+ instead of competing with 
the Na+ or u+ binding sites on the membrane. The data without membrane (Tables 8 and 9) 
are control experiments for 3 mM Na+ or 3 mM u+ in 5H8, which is the buffer system used 
for the membrane study. The relaxation times with and without amiloride showed no 
significant difference, indicating there is no specific interaction between Na+ or Li+ and 
amiloride. Phloretin, in the same concentration range as for amiloride, caused increases 
on 7Li NMR relaxation times (Figure 10, Table 10) but had no significant effect on 23Na NMR 
relaxation times (Table 11). This indicates that the effect of phloretin on the metal ion binding 
to the RBC membrane is smaller than that of amiloride. To test if phloretin bound metal ions, 
control experiments were done by measuring the 23Na and 7Li relaxation times in the buffer 
with and without phloretin. There was no significant change in the relaxation times (Tables 
10 and 11) indicating that there is no significant binding of Na+ or Lt to phloretin. 
3. Na+ -H+ Transport Measurement by 23Na and 31P NMR 
3.1. Na+ influx measurement by 23Na NMR 
Using AA, the Na+-H+ transport rate was measured in acid loaded cells (39). The 
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Figure 8. 23Na T, measurements for membrane samples in the presence of amiloride. A 2.5 
ml unsealed membrane with 3 mM NaCl is placed in a 10 mm NMR tube for the T, 
measurement. The 500 mM amiloride solution (DMSO solvent) was added to the tube to 
obtain the T, values with inhibitors. The protein concentrations of the two membrane samples 
were 8.82 and 9.36 mg/ml. 
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Table 8. 23Na T1 measurements for membrane samples in the presence of amiloride. Same 
conditions as for Figure 8. The values in the table below have the unit of ms. 
A: with membrane 
OmMA 
41±1 
40±1 
B: without membrane 
71±3 
69±1 
1 mMA 
45±3 
43±3 
2mMA 
44±1 
43±2 
4mMA 
49±2 
51±2 
6mMA 
55±2 
54±1 
70±2 
70±2 
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Figure 9. 7Li T1 measurements for membrane samples in the presence of amiloride. A 2.5 ml 
unsealed membrane with 3 mM LiCl is in the 10 mm NMR tube. The 500 mM amiloride 
stock solution in DMSO solvent was added to the NMR tube after the first measurement 
without inhibitors. The membranes in this experiment have protein concentrations of 8.9 and 
9.0 mg/ml. 
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Table 9. 7Li T1 measurements for membrane samples in the presence of amiloride. Same 
conditions as for Figure 9. The data in this table have the unit of s. 
OmMA 
A: with membrane 
7.9±0.6 
7.4±0.4 
B: without membrane 
22±1 
21±2 
lmMA 
8.1±0.4 
8.2±0.5 
2mMA 
9.2±0.7 
10.1±0.8 
4mMA 
12.0±0.5 
11.6±0.4 
6mMA 
12.4±0.7 
13.9±0.4 
21±1 
23±1 
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Figure 10. Effect of phloretin on 7Li NMR relaxation times in unsealed membrane. A 
phloretin stock solution of 200 mM in DMSO was added to a 2.5 ml membrane sample with 
3 mM LiCI. The protein concentrations of these two samples were 9.3 and 9.2 mg/ml. 
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Table 10. Effect of phloretin on 7Li NMR relaxation times in unsealed membrane. Same 
conditions as for Figure 10. For the control experiment, 2 mM phloretin was added to 2.5 
ml 5H8 buffer with 3 mM LiCI. The data in this table have units of s. 
OmMP 0.3 mM P 0.6 mM P 0.9 mM P 1.2 mM P 1.5 mM P 2.0 mM P 
A: with membrane 
6.9±0.3 
6.6±0.4 
7.8±0.7 
6.6±0.4 
B: without membrane 
21±2 
22±1 
6.9±0.4 
7.2±0.9 
7.9±0.6 
6.9±0.4 
8.6±0.4 
7.6±0.6 
9.4±0.7 8.8±0.8 
7.4±0.8 7.6±0.4 
23±1 
20±2 
In order to compare the effects of phloretin and amiloride, I tested the competition 
effect of phloretin (up to a concentration of 6 mM) with and without membrane. The protein 
concentration in this membrane sample was 8.5 mg/ml. 
OmMP 1 mMP 2mMP 4mMP 6mMP 
A: with membrane 
6.8±0.2 8.8±0.7 9.2±0.3 9.6±0.6 9.0±0.3 
B: without membrane 
21±2 21±1 
22±1 20±2 
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Table 11. Effect of phloretin on 23Na NMR relaxation times in unsealed membrane. A 200 
mM phloretin stock solution in DMSO solvent was added to 2.5 ml unsealed membrane sample 
which has 3 mM NaCl. The data with the unit of ms. The protein concentrations of the 
membrane samples were 8.0 and 8.9 mg/ml. For the control experiment with phloretin, a 
stock solution of 200 mM phloretin was added to 2.5 ml 5H8 with 3 mM NaCl. 
OmM 
A: with membrane 
44±3 
44±2 
B: without membrane 
71±3 
69±1 
0.3 mM 
42±3 
44±3 
0.6mM 
40±2 
45±2 
1.2 mM 
39±2 
45±2 
2.0mM 
42±2 
45±3 
70±2 
70±1 
In order to test the phloretin effect at the same concentration as amiloride, I added 
phloretin to the membrane sample up to a concentration of 6 mM. The membrane sample had 
a protein concentration of 8.7 mg/ml. 
OmM 
A: with membrane 
45±2 
B: without membrane 
69±1 
1 mM 
41±2 
2mM 4mM 6mM 
41±1 44±1 43±1 
70±1 
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Na+ -H + transport rate that I obtained at 2 % hematocrit was 34 mmol/L cell/hr without 
amiloride and 8.8 mmol/L cell/hr with amiloride. Thus 74% Na+ influx was inhibited by 
amiloride, in agreement with Canessa's values of 10-40 mmol/L cell/hr for Na+ -H+ transport 
rate and 60-80 % of this transport being sensitive to amiloride (39). 
The shift reagent Dy(TTHAl was used to distinguish the pools of Na+ inside and 
outside the RBC membrane (Figure 11). The extracellular Na+ which surrounded Dy(TTHAl 
yielded the downfield peak. The transport rate was obtained by measuring the peak area 
changes of intra- and extracellular Na+ resonances (see Methods). The spectra show that as 
time increased the intracellular Na+ peak increased, increasing faster in the pH 8.0 medium 
than in the pH 6.0 medium (Figure 12). The rate obtained from NMR spectra at 20% 
hematocrit for Na+ depleted cells at 1 hour observation time was 0.40 mmol/L cell/hr which 
varied among individual blood samples (Table 12). The rates from NMR were smaller than 
the rates from AA. This is because the NMR measurements were done at a higher hematocrit 
and over a longer observation time. The hematocrit and the extracellular [Na+] effects were 
also studied by 23Na NMR (Tables 13-15). At 70% Ht and 150 mM NaCl in suspension, the 
transport rate was 9.3 mmol/L cell/hr. By decreasing the Ht to 35%, the rate increased to 39 
mmol/L cell/hr. At 35% Ht, decreasing [Na+] in the suspension from 150 mM to 65 mM, the 
rate decreased to 33 mmol/L cell/hr. As the observation time of these experiments was 10 
minutes, these rates were higher than the rate at 1 hour observation time. The percentage of 
cell lysis is below 5% for all Na+ influx experiments using NMR. The calculated rates for 
duplicate samples at 70% Ht, 150 mM NaCl in suspension were 9.3 and 3.2 mmol/L cell/hr, 
with a coefficient of variation of 69 % . 
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F1gure 11. 23Na NMR spectrum of inner and outer tube combination. The inner tube contains 
25 mM NaCl and the outer tube contains 119 mM NaCl, 7 mM Na.iDy(TIHA), 10 mM 
glucose, 10 mM HEPES pH=7.4. 
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Figure 12. Na+ influx rate measurements by 23Na NMR. The acid loaded RBCs (see Methods) 
were put into two Na+ influx media (129 mM NaCl, 7 mM NC!:JDy(ITHA), 10 mM glucose, 
10 mM buffer, Tris-MES for pH=6.0, Tris-MOPS for pH=8.0, 0.01 mM bumetanide, 0.1 
mM ouabain). The osmolarity of both media was 370± 10 mosm to prevent swelling in acid 
loaded RBCs by increased Cr content. The hematocrit of both suspensions was 20%. 
Time/min 
2.5 
22.5 
42.5 
pH=8.0 
f \ 
I 
58 
pH=6.0 
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Table 12. Na+ influx rate measurements by 23Na NMR at 20% Ht for 1 hour. The RBCs used 
in this experiment were pretreated with nystatin to deplete intracellular sodium. The Na+ -H+ 
transport rate from this sample is 0.40 mmol/L cell/hr (n= 1). 
Time/min Peakout Ratioin/out 
pH 6.0 medium: slope=0.0106 mM/min, r2 =0.8100. 
2.5 0.3801 0.0080 0.021 0.80 
12.5 0.4002 0.0076 0.019 0.72 
22.5 0.4028 0.0105 0.026 0.98 
32.5 0.4128 0.0108 0.026 0.98 
42.5 0.4141 0.0133 0.032 1.20 
pH=8.0 medium: slope=0.0172 mM/min, r2=0.9078. 
2.5 0.3705 0.0076 0.021 0.78 
12.5 0.3824 0.0098 0.026 0.97 
22.5 0.3897 0.0110 0.028 1.06 
32.5 0.3924 0.0120 0.031 1.15 
42.5 0.3869 0.0161 0.042 1.55 
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Table 13. Na+ influx measurements by 23Na NMR at 70% Ht for 10 minutes. Same 
suspension conditions as for Figure 12. The transport rate of this sample was 9.3 mmol/L 
cell/hr (n= 1). 
Time/min 
pH 8.0 medium: slope=0.3025 mM/min, r2=0.9626. 
2 
6 
10 
75.804 
76.220 
76.968 
16.385 
19.364 
20.056 
pH 6.0 medium: slope=0.2250 mM/min, r2 =0.7500. 
2 
6 
10 
92.595 
91.438 
91.927 
13.667 
14.988 
15.055 
Ratioin/ou1 
0.216 
0.254 
0.261 
0.148 
0.164 
0.164 
14.07 
16.13 
16.49 
12.36 
13.54 
13.54 
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Table 14. Na+ influx rate measurements by 23Na NMR at 35% Ht for 10 min. Same 
suspension conditions as for Figure 12. The transport rate was 39 mmol/L cell/hr (n= 1). 
Time/min Peakoui 
pH 8.0 medium: slope=0.660 mM/min, r=0.8957. 
2 163.48 7.28 
6 164.85 10.30 
10 166.70 11.20 
pH 6.0 medium: slope=0.011 mM/min, r=0.7674. 
2 196.74 10.90 
6 201.98 11.01 
10 203.53 11.33 
Ratioin/oui 
0.0445 
0.0625 
0.0672 
0.0554 
0.0545 
0.0557 
10.90 
15.10 
16.18 
16.63 
16.37 
16.72 
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Table 15. Na+ influx rate measurements by 23Na NMR at 35% Ht for 10 min at low 
extracellular [Na+]. Same suspension conditions as for Figure 12, expect that [Na+] in 
suspension is 65 mM. The trasnport rate of this sample was 33 mmol/L cell/hr (n= 1). 
Time/min Peakout 
pH 8.0 medium: slope=0.595 mM/min, r2=0.8576. 
2 100.448 10. 778 
6 101.570 13.190 
10 102.370 13.710 
pH 6.0 medium: slope=0.046, r2=0.9998. 
2 93.046 8.360 
6 95.182 8.677 
10 95.762 8.957 
Ratioin/out 
0.107 
0.130 
0.134 
0.0898 
0.0912 
0.0926 
20.86 
24.92 
25.62 
12.69 
12.87 
13.06 
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3.2. Na+ emux measurement by 2.lNa NMR 
As we can see from the 23Na NMR spectra, shown in Figure 12, because of large 
concentration differences, the intracellular Na+ peak areas were very small compared with the 
extracellular Na+ peak areas. It was therefore hard to determine accurately the intracellular 
Na+ concentration changes by integrating the small intracellular peaks. A Na+ efflux 
measurement method was developed by placing Na+ -loaded cells in two media at different pH 
values to better observe changes in intracellular Na+ concentrations and more accurately 
measure the rate of RBC Na+-H+ exchange using 23Na NMR (Figure 13 and Tables 16,17,18). 
As time increased, the intracellular Na+ peak decreased, decreasing faster in the pH 6.0 
medium than in the pH 8.0 medium (Figure 13, Table 16). The rate of Na+ efflux varied 
among individual blood samples and was in the range 3 to 13 mmol/L cell/hr (Table 16, 17, 
18). The data in Tables 17 and 18 are duplicates of the same blood sample. The rates were 
4.7 and 3.3 mmol/L cell/hr for the same blood sample indicating that the intraindividual 
reproducibility (coefficient of variation 25 % ) of Na+ efflux measurements was better than that 
of Na+ influx measurements. The percentage of cell lysis in Na+ efflux measurements was less 
than 2%. 
3.3. Measurement of intracellular pH in RBC by 31P NMR 
When the intracellular Na+ concentration changed in acid-loaded cells, the intracellular 
pH also changed due to Na+ -H+ transport. The indicator methylphosphonic acid (MeP) was 
used to obtain intracellular pH measurements by 31P NMR spectroscopy (44,45). From pH 6.0 
to pH 8.0, the pH dependence of MeP-inorganic phosphate chemical shift has a sensitivity of 
0.39 pH unit/ppm, independent of the hemoglobin oxygenation state (45). The acid-loaded 
RBCs with an intracellular pH 6.29 were put into two different pH suspension media, pH 6.0 
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Figure 13. Na+ efflux rate measurements by 23Na NMR. Na+ loaded RBCs were put into two 
pH suspension media (150 mM KCl, 7 mM Dy(ITHAt in Tris form, 0.15 mM MgC12, 10 
mM glucose, 10 mM buffer, Tris-MES for pH=6.0 and Tris-MOPS for pH=8.0, 0.1 mM 
ouabain, 0.01 mM bumetanide.) The hematocrits of both solutions were 20%. 
Time(mirr) 
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Table 16. Na+ efflux rate measurements by 23Na NMR. Same conditions as for Figure 13. 
The starting intracellular sodium concentration was 63 mM. The sodium efflux rate was 13 
mmol/L cell/hr (n= 1). 
Time/min 
pH 8.0 medium: slope=-0.1932 mM/min, r=0.7783. 
2.5 0.0179 0.1818 10.1564 56.10 
17.5 0.0211 0.1874 8.8815 55.23 
32.5 0.0213 0.1818 8.5352 54.95 
47.5 0.0315 0.1746 5.5429 51.41 
62.5 0.0582 0.1625 2.7921 43.52 
pH 6.0 medium: slope=-0.4118 mM/min, r=0.9216. 
2.5 0.0167 0.1771 10.60 56.36 
17.5 0.0181 0.1880 10.39 56.23 
32.5 0.0364 0.1730 4.75 49.88 
47.5 0.0762 0.1488 1.95 38.41 
62.5 0.0972 0.1460 1.50 34.39 
67 
Table 17. Na+ efflux rate measurements by 23Na NMR. Same conditions as for Figure 13. 
The sodium efllux rate was 4.7 mmol/L cell/hr (n= 1). 
Time/min Peakout Ratioin/au1 
pH 8.0 medium: slope=-0.1150 mM/min, r=0.8708. 
2.5 0.0182 0.3223 17.7088 37.36 
17.5 0.0198 0.3201 16.1667 37.13 
32.5 0.0258 0.3210 12.4419 36.35 
47.5 0.0473 0.3118 6.5920 33.62 
62.5 0.0722 0.2893 4.0069 30.49 
pH 6.0 medium: slope=-0.1931 mM/min, r=0.9111. 
2.5 0.0164 0.3518 21.4512 37.80 
17.5 0.0199 0.3604 18.1106 37.42 
32.5 0.0351 0.3491 9.9459 35.53 
47.5 0.0812 0.3229 3.9766 30.43 
62.5 0.113 0.2828 2.5409 26.81 
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Table 18. Na+ efflux rate measurements by 23Na NMR. Same conditions as for Figure 13. 
The sodium efllux rate was 3.3 mmol/L cell/hr (n= 1). 
Time/min PeakOUI Ratioin/au1 
pH 8.0 medium: slope=-0.1333 mM/min, r2=0.9004. 
2.5 0.0203 0.3172 15.6256 37.04 
17.5 0.0219 0.3063 13.9909 36.72 
32.5 0.0320 0.3119 9.7469 35.45 
47.5 0.0548 0.2982 5.4416 32.53 
62.5 0.0827 0.2771 3.3507 29.13 
pH 6.0 medium: slope=-0.1875 mM/min, r2=0.9084. 
2.5 0.0279 0.3531 12.6559 36.40 
17.5 0.0283 0.3566 12.6007 36.39 
32.5 0.0478 0.3485 7.2908 34.15 
47.5 0.0916 0.3031 3.3090 29.03 
62.5 0.1246 0.2899 2.3266 26.02 
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and pH 8.0. After one hour incubation at 37 °C, the RBCs in pH 6.0 suspension had 
pHi=6.17±0.05 (n=2), the RBCs in pH 8.0 suspension had plf;=6.52±0.03 (n=2) (Table 
19). These intracellular pH change are a result of Na+ -H+ exchange. In the pH 8.0 
suspension there was a larger pH gradient than in the pH 6.0 suspension. Na+ influx will 
predominate in the pH 8.0 sample replacing intracellular H+ and increasing intracellular pH. 
In the pH 6.0 suspension the intracellular pH was similar to that of the extracellular pH, so 
there were no significant changes in the cell pH. The initial intracellular pH varied among 
individual samples. The sample showed in Figure 14 had a starting intracellular pH 6.7 and 
after 30 minutes incubation in pH 5.7 and pH 8.0 media, the final cell pH values were 6.4 and 
6.9. 
4. Transport Rates and Relaxation Time Measurements in RBCs from Hypertensive 
Patients 
All hypertensive patients were white and had diastolic blood pressure higher than 90 
mmHg. The Na+-u+ and Na+ -H+ transport rates were measured by AA in intact RBCs from 
five hypertensive patients (see Methods). The 7Li and 23Na T1 relaxation times were measured 
on the membrane prepared from patient's blood (Table 20). I only studied blood samples from 
five hypertensive patients. The sample size was too small to do statistical analysis and draw 
any conclusions concerning the involvement of these two ion transport pathways in 
hypertension. 
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Table 19. The intracellular pH ofRBCs obtained from MeP and P; chemical shift. RBCs were 
placed in acid- and MeP loading suspension medium (130 mM KCl, 20 mM MeP, 10 mM 
glucose, 20 mM Tris-Mes buffer, pH=5.7, 0.15 mM MgC12, 0.1 mM ouabain, 0.01 mM 
bumetanide) for 10 minutes at 37 °C and 10% Ht, then methazolamide and DIDS were added 
and incubated for another 30 minutes. The cells were then washed four times with AWS. The 
acid and MeP loaded RBCs were finally placed into two different pH 6.0 and 8.0 suspension 
media for 1 hour. The 31P NMR spectra were taken from packed RBCs before and after 1 
hour incubation at 37 °C. The blood sample used for this experiment is different form that 
used for Figure 15. 
Time 0 
pH 8.0 
pH 6.0 
0.66 
0.82 
0.76 
0.41 
0.65 
Chemical Shift 
MeP 
23.97 
23.44 
23.44 
23.74 
23.03 
23.21 
22.62 
22.68 
23.33 
23.38 
6.29 
6.54 
6.50 
6.20 
6.13 
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Figure 14. Intracellular pH changes during Na+-H+ exchange measured by 31P NMR. MeP 
was loaded into the RBCs and intracellular pH was obtained from the chemical shift separation 
between the MeP and the Pi peaks. The MeP loaded RBCs was placed into two pH 
suspensions of 5.7 and 8.0. After 30 minutes, the cells were centrifuged and packed to take 
31P NMR spectra. The pH was obtained from the standard curve of Labotka et al. (44). (A) 
Time 0 minute. Cell pH=6.7. (B) 30 minutes in pH 5.7 suspension. Cell pH=6.4. (C) 30 
minutes in pH 8.0 suspension. Cell pH=6.9. 
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Table 20. Transport rates and NMR relaxation time measurements in RBCs from hypertensive patients. The 23 Na T 1 was measured for 
29 mM NaCl in membrane, and the 7Li T 1 was measured for 11 mM LiCl in membrane. 
Patient [Protein] 
mmol/L cell/hr mmol/L cell/hr ms s mg/ml 
1 0.25 28.9 58.2 12.0 1012 2179 6.78 
2 0.17 20.8 56.9 9.85 119 121 6.68 
3 0.45 3.75 58.2 7.86 3548 123 5.00 
4 0.20 2.60 60.7 13.0 96 1195 5.34 
5 0.13 4.90 61.0 7.02 280 131 5.20 
CHAPTER V 
DISCUSSION 
1. 23Na and 7Li NMR Relaxation Time Study of Na+ -H+ Exchange Protein in the Human 
RBC Membrane 
Canessa, M. (11) reported that the binding of alkaline metal ions for the human RBC 
membrane exchange protein had the relative affinity H+ > > u+ >Na+. We anticipated that 
the intracellular pH will change the distribution of free and bound intracellular Na+ and 23Na 
NMR relaxation times. As expected, when the intracellular pH decreased, the T1 and T2 values 
of 23Na in the acid-loaded RBCs increased (Table 1, Figure 2). Because a small difference in 
relaxation times between two blood samples occurred, one may conclude that this is due to 
variations in intracellular sodium concentration. The 23Na relaxation values were 30.6±0.8 ms 
for T1 and 10.6±0.6 ms for T2 in pH 7.4, and 39.4±2.7 ms for T1 and 15.9±2.3 ms for T2 
in pH 5.8 cells in the intracellular sodium concentration range 1.0 to 22 mM. Therefore by 
studying the effect of intracellular sodium concentration on relaxation times (Table 2, Figure 
3), in a large range of sodium concentrations, we found, however, that the 23Na NMR 
relaxation times were not significantly different. There was, however, a significant difference 
in 23Na relaxation values between cells at two different intracellular pH values. An increase 
in intracellular pH caused a decrease in 23Na NMR relaxation times, indicating that protons 
compete with Na+ binding sites in human RBCs. As the pH could also change the oxygenation 
state of RBCs, the Bohr effect was studied in N2 and CO RBCs (Table 3). The 23Na NMR 
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relaxation times showed no significant difference in the three different oxygenation states ruling 
out this possibility. 
Studies on unsealed membrane were conducted for both Na+ and u+ ions. The pH 
effect on 23Na and 7Li relaxation times found with intact RBCs was also observed with 
membrane. In the low intracellular sodium concentration range (2.0 to 8.0 mM), the 23Na T1 
values were lower in the pH 8.0 samples than those in the pH 6.5 samples (Table 5, Figure 
5), which indicated that H+ competed with Na+ ions. In the high sodium concentration range, 
however, the binding sites start being saturated and the relaxation times in two different pH 
samples were similar. The pH effect was also shown with u+ ions on membrane samples. 
By decreasing the pH of the membrane samples, the T1 values of 7Li NMR increased, 
indicating a competition between H+ and Li+ (Table 6, Figure 6). When decreasing the pH 
of membrane samples, the 23Na NMR T1 values increased only slightly (Table 7, Figure 7). 
This is because the binding of Na+ ions was weaker than the binding of Li+ ions to the Na+ -
H+ exchange protein (11), and therefore the competition between H+ and Na+ was not as 
pronounced as the competition between H+ and u+. Adding u+ ions to the membrane 
samples already containing Na+, resulted in an increase in the 23Na NMR relaxation times in 
the pH range from 6.8 to 7.8 (Table 7, Figure 7). This indicates again that Lt competes with 
Na+ binding sites in the human RBC membrane. 
Using James-Noggle plots (53), we generated the binding constants for Na+ to the RBC 
membrane. The binding constant, ~' to the RBC membrane, is calculated by using T1 values 
and assuming a two-state (free and bound Na+ ions) model undergoing fast exchange: 
AR."1 = (Robs-Rr..,.}1 = ~-t {[BJ(R--Rr..,.,) }"1 + [M+]{[B](ROOund-Rr..,.,) }"1, 
where [M+] and [B] are the total concentrations of Na+ ions and membrane binding sites. The 
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Figure 15. James-Noggle plot for the Na+ binding constants to the RBC membrane at two 
different pH values. Using the average data from Table 5, the binding constants for membrane 
samples at pH 8.0 and pH 6.5 were generated by taking the slope of the line and dividing it 
by the Y axis intercept. The binding constants were 96 M"1 at pH 6.5 and 493 M-1 at pH 8.0. 
The squares denote data for the pH 8.0 sample and the pluses are for the pH 6.5 sample. 
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Na+ binding constant in unsealed human RBC membrane was 96±33 M-1 {n=3; r2 =0.96) at 
pHin 6.5 and 493± 106 M·1 {n=3; r2 =0.98) for pHin 8.0 (Figure 15) which is consistent with 
weaker Na+ binding at acidic intracellular pH. 
Amiloride and phloretin show competition effects on both Na+ and u+ NMR relaxation 
times. By adding 6 mM amiloride to membrane, the 7Li T1 increased by 70% (Table 9) and 
the 23Na T1 increased by 35% (Table 8). As u+ binds more strongly than Na+ (11), amiloride 
showed a stronger effect on 7Li+ T1 values. Phloretin (at 6 mM) increased the 7Li T1 values 
by 32% (Table 10), but showed no effect on the 23Na T1 values (Table 11). Because phloretin 
binds more weakly to the membrane than amiloride, it can not show any appreciable effect on 
the weakly bound Na+. 
2. NMR Measurements of Na+ -H+ Exchange in human RBC suspensions 
Using 23Na NMR spectroscopy, we showed that the intra- and extracellular Na+ peaks 
changed with time for acid-loaded and Na+ -depleted RBCs suspended at two different pH 
values (Table 12). We studied the hematocrit effect on the rate of Na+ -H+ exchange for acid-
loaded RBCs (Table 13, 14). As the hematocrit decreased, the Na+ -H+ exchange rate 
increased as expected. At low hematocrit, fewer cells are surrounded by more Na+ in the 
suspension, which causes fast Na+ influx. By decreasing the Na+ concentration in the 
suspension at the same hematocrit, the exchange rate decreased as expected (Table 15). 
For Na+ efflux measurements, we loaded RBCs with Na+ using nystatin treatment. 
The final intracellular sodium concentration after loading was hard to control. For the same 
starting extracellular sodium concentration (150 mM) and 10% Ht, the final [Na+]in varied from 
35 to 60 mM, and the sodium efflux rate varied from sample to sample. The intraindividual 
reproducability was, however, excellent with an error of approximately 1 mmol/L cell/hr 
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(Tables 17 and 18). The coefficient of variation for Na+ efflux was 25% as opposed to 69% 
for Na+ influx measurements, which indicated that the 23Na NMR method has a higher 
reproducibility under Na+ efflux conditions. As the binding affinity of the transport membrane 
protein for Na+ is not the same on both sides of the cell membrane (11), the NMR determined 
rates for Na+-H+ exchange measured under Na+ efflux conditions are not comparable with the 
AA determined rates of Na+ -H+ exchange measured under Na+ influx conditions. It is 
therefore possible to use one dimensional 23Na NMR spectroscopy to monitor the Na+ 
concentration changes in RBCs undergoing Na+ -H+ exchange. 
31P NMR spectroscopy was used successfully to detect intracellular pH changes during 
Na+ -H+ transport (Table 19). By placing acid-loaded RBCs in two Na+ influx media at 
different pH values, the intracellular pH increased in the pH 8.0 medium due to the large pH 
gradient but did not change appreciably in the pH 6.0 medium where a smaller pH gradient 
was present (Table 19). 
The question concerning Na+-H+ exchange and Na+ -Li+ countertransport being 
mediated by the same or a different transport protein in human RBC membranes has been 
studied by many investigators (3, 9-12, 21-26). The effect of inhibitors is controversial. 
Amiloride-sensitive Na+ -H+ transport is activated by cytoplasmic lithium (9) but amiloride 
showed no inhibition effect on Na+ -Li+ countertransport (22, 23). This could due to the 
improper experimental conditions used in the previous studies or due to the insensitivity of the 
assay transport methods. We worked directly with the human RBC membrane where the 
transport protein is located. Our study showed that amiloride, which was previously known 
as only an inhibitor for Na+ -H+ exchange, competed with both Na+ and Li+ ions in human 
RBC membrane. We were unable to observe phloretin competition with Na+ ions for the RBC 
membrane. This was because phloretin showed weaker binding than amiloride for the RBC 
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membrane as manifested by the smaller changes in the 7Li NMR relaxation times for the same 
inhibitor concentrations (fables 9 and 10). We also expected, however, that phloretin 
competed more weakly with Na+ than did amiloride. It is therefore not surprising that we 
were unable to detect competition between phloretin and Na+ for the human RBC membrane. 
Our relaxation data in the presence of amiloride are therefore consistent with the idea that Na+ -
H+ exchange and Na+-u+ countertransport are mediated by the same membrane transport 
protein in human RBCs. 
Our ion transport results show that alkaline metal NMR spectroscopy is a sensitive 
method to study Na+ -H+ and Na+ -Li+ transport in human RBCs. Future studies should focus 
on the application of the NMR methods to blood samples from hypertensive and manic 
depressive patients. It would be exciting to know whether the rates of Na+ -H+ and Na+-u+ 
exchange are correlated to the binding of metal ions to the human RBC membrane in these 
disease states. NMR relaxation time studies of RBCs from hypertensive and manic-depressive 
patients could provide novel binding information which may lead to a molecular understanding 
of the etiology of essential hypertension and/or manic-depression. 
APPENDIX I 
DERIVATION OF EQUATION 3 
The total number of mmol Na+=[Na+]aut0x(l-Ht)XVIOla)+[Na+]imlxHtxVtotal (1) 
The total number of mmol Na+=number of mmol Na\,+number of mmol Na\. (2) 
R=Ratio ofmmol Na+in/(mmol Na\Ulx0.8) (3) 
From (3), the number of mmol Na\,11 =mmol Na+ in/(0.8 xR) (4) 
Combining (2) and (4), 
The total number of mmol Na+= {1+1/(0.8 xR)} xnumber of mmol Na+ in (5) 
[Na+]in=mmol Na+ in/(HtxV,ota1) (6) 
Combining (5) and (6), 
HtxV,ota1[Na+]in=total number of mmol of Na+/{1+1/(0.8 xR)} (7) 
Combining (1) and (7), 
{1+1/(0.8 xR)} x (HtxV total x [Na+]j= {[Na +1aut0 x (1-Ht)+ [Na+]iml xHt} xV total (8) 
Canceling the V toCa) term from both sides, equation (8) becomes equation (9) for the calculation 
of intracellular Na+ concentration: 
[Na+]in = {[Na+]out0 x (1-Ht)+ [Na+]iml XHt}/{Htx (1+1/0.8R)} 
The meaning of the symbols is as follows: 
(9) 
[Na+]aut0 is the [Na+] in suspension at time 0 min, Ht is the hematocrit of cell 
suspension, V,Ola1 is the volume of sample in NMR tube, and [Na+]iml is intracellular [Na+] at 
time 0 min. 
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APPENDIX II 
·DERIVATION OF EQUATION 4 
The total number of mmol Na+=[Na+]imlxHtxV,o1a1 
The total number of mmol Na+=mmol Na+ in +mmol Na+ cut 
R=Ratio of mmol Na+ in/(mmol Na\"' x0.8) 
From (3), mmol Na\11 =mmol Na+in/(0.8xR) 
Combining (2) and (4), 
The total number of mmol Na+={l + 1/(0.8xR)} xnumber of mmol Na+ in 
Combing (1) and (5), 
mmol Na+ inx(l + 1/0.8R)=[Na+]imlxHtxVtotal 
[Na+]in=mmol Na+ in/(HtxVtotal) 
Combining (6) and (7), 
Ht xv total x [Na +]in= [Na +]DI XHt xv 1oa1/(l + 1/0.8R) 
Canceling the V total and Ht term from both sides, we have 
[Na+]in=[Na+]iml/(1+1/0.8R) 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
(9) 
The meaning of the symbols used above is the same as for the derivation of equation 
(3) shown in the previous page. 
82 
BIBLIOGRAPHY 
1. Nakhoul, N.L., Boron, W.F.: Physiological roles of Na+-H+ exchange in epithelial 
cells. In Grinstein, S. (ed.) Na+ -H+ Exchange. Boca Raton, FL: CRC Press, Inc., 
1988, pp 167-178. 
2. Mahnensmith, R.L., Aronson, P.S.: The plasma membrane sodium-hydrogen exchanger 
and its role in physiological and pathophysiological processes. Circ. Res. Q: 773-788, 
1985. 
3. Semplicini, A., Mozzato, M.G., Sama, B., Nosadini, R., Fioretto, P., Trevisan, R., 
Pessina, A.C., Crepaldi, G., Palu, C.D.: Na+-H+ and u+-Na+ exchange in red blood 
cells of normotensive and hypertensive patients with insulin dependent diabetes mellitus 
(IDDM). Am. J. Hypertension 2.: 174-177, 1989. 
4. Lifton, R.P., Sardet, C., Pouyssegur, J., Lalouel, J.M.: Cloning of human genomic 
amiloride-sensitive Na+ -H+ antiporter gene, identification of genetic polymorphisms and 
localization on the genetic map of chromosome lp. Genomics 1: 131-135, 1990. 
5. Escobales, N., Canessa, M.: Amiloride-sensitive Na+ transport in human red cells: 
Evidence for a Na+-H+ exchange system. J. Membr. Biol. 90: 21-28, 1986. 
6. Escobales, N., Canessa, M.: Ca2+ -activated Na+ fluxes in human red cells. J. Biol. 
Chem. 260: 11914-11923, 1985. 
7. Dascalu, A., Nevo, Z., Korenstein, R.: Regulation of the Na+-H+ exchanger under 
conditions of abolished proton gradient: isosmotic and hyperosmotic stimulation. FEBS 
Lett. 282: 305-309, 1991. 
8. Aronson, P.S., Nee, J., Suhm, M.A.: Modifier role of internal H+ in activating the 
Na+-H+ exchanger in renal microvillus membrane vesicles. Nature (London) 299: 161, 
1982. 
9. Parker, J.C.: Interactions of lithium and protons with sodium-proton exchanger of dog 
red blood cells. J. Gen. Physiol. 87: 189, 1986. 
10. Schmalzing, G., Schlosser, T., Kutschers, P.: Li+ as a substrate of the synaptosomal 
Na+-H+ antiporter. J. Biol. Chem. 261: 2759, 1986. 
11. Canessa, M., Morgan, K., Semplicini, A.: Genetic differences in lithium-sodium 
exchange and regulation of the sodium-hydrogen exchanger in essential hypertension. 
J. Cardiovasc. Pharmacol. 12: S92-S98, 1988. 
83 
84 
12. Canessa, M., Brugnara, C., Escobales, N.: The u+-Na+ exchange and Na+-K+-cr 
cotrasport systems in essential hypertension. Hypertension 10: I4-10, 1987. 
13. Williams, R.R., Hunt, S.C., Wu, L.L., Hasstedt, S.J., Hopkins, P.N., Ash, K.O.: 
Genetic and epidemiological studies on electrolyte transport systems in hypertension. 
Clin. Physiol. Biochem. Q: 136-149, 1988. 
14. Dorus, E., Cox, N.J., Gibbons, R.D., Shaughnessy, R., Pandey, G.N., Cloninger, 
C.R.: Lithium ion transport and affective disorders within families of bipolar patient: 
Identification of a major gene locus. Arch. Gen. Psychiatry 40: 545-552, 1983. 
15. Hannaert, P.A., Garay, R.P.: A kinetic analysis of Na+ -Li+ countertransport in human 
red blood cells. J. Gen. Physiol. .81: 353-368, 1986. 
16. Sarkadi, B., Alifimoff, J.K., Gunn, R.B., Tosteson, D.C.: Kinetics and stoichiometry 
of Na+-dependent u+ transport in human red blood cells. J. Gen. Physiol. 72: 249-
265, 1978. 
17. Mota de Freitas, D.E., Espanol, M.T., Dorus, E.: Lithium transport in red blood cells 
of bipolar patients. Lithium Therapy Monographs ,4: 96-120, 1991. 
18. Canessa, M., Adragna, N., Solomon, H.S., Connolly, T.M., Tosteson, D.C.: Increased 
sodium-lithium countertransport in red cells of patients with essential hypertension. N. 
Engl. J. Med. 302: 772, 1980. 
19. Weder, A.B., Schork, N.J.: Mixture analysis of erythrocyte lithium-sodium 
countertransport and blood pressure. Hypertension .U: 145-150, 1989. 
20. Weinberger, M.H., Smith, J.B., Fineberg, N.S., Luft, F.C.: Red-cell sodium-lithium 
countertransport and fractional excretion of lithium in normal and hypertensive human. 
Hypertension .U: 206-212, 1989. 
21. Semplicini, A., Canessa, M., Mozatto, M.G., Ceolotto, G., Marzola, M., Buzzaccarini, 
F., Casolino, P., Pessina, A.C.: Red blood cell Na+-H+ and u+-Na+ exchange in 
patients with essential hypertension. Am. J. Hypertension Z.: 903-908, 1989. 
22. Pandey, G.N., Sarkadi, B., Haas, M., Gunn, R.B., Davis, J.M., Tosteson, D.C.: 
Lithium transport pathways in human red blood cells. J. Gen. Physiol. 72: 233-247, 
1978. 
23. Carr, S., Thomas, T.H., Wilkinson, R.: Sodium-lithium countertransport activity and 
its sensitivity to inhibitors with erythrocyte ageing in man. Clin. Chim. Acta 178: 51-
58, 1988. 
24. Jennings, M.L., Adams-Lackey, M., Cook, K.W.: Absence of significant sodium-
hydrogen exchange by rabbit erythrocyte sodium-lithium countertransporter. Am. J. 
Physiol. 249: C63-C68, 1985. 
85 
25. Kahn, A.M.: Difference between human red blood cell Na+-u+ countertransport and 
renal Na+-H+ exchange. Hmertension 2: 7-12, 1987. 
26. Kahn, A.M., Allen, J.C., Cragoe Jr., E.J., Shelat, H.: Sodium-lithium exchange and 
sodium-proton exchange are mediated by the same transport system in sarcolemmal 
vesicles from bovine superior mesenteric artery. Circ. Res. 65: 818-828, 1989. 
27. Pandey, G.N., Ostrow, D.G., Hass, M., Dorus, E., Casper, R.C., Davis, J.M., 
Tosteson, D.C.: Abnormal lithium and sodium transport in erythrocytes of a manic 
patient and some members of his family. Proc. Natl. Acad. Sci. USA 74: 3607-3611, 
1977. 
28. Mota de Freitas, D.E., Silberg, J., Espanol, M.T., Dorus, E., Abraha, A., Dorus, W., 
Elenz, E., Whang, W.: Measurement of lithium transport in RBC from psychiatric 
patients receiving lithium carbonate and normal individuals by 7Li NMR spectroscopy. 
Biol. Psychiatry 28: 415-424, 1990. 
29. Ramasamy, R., Mota de Freitas, D.E., Bansal, V.K., Dorus, E., Laboka, R.: Nuclear 
magnetic resonance studies of lithium transport in erythrocyte suspensions of 
hypertensives. Clin. Chim. Acta 188: 169-176, 1990. 
30. Springer, C.S. Jr.: Transmembrane ion pumping: High resolution cation NMR 
spectroscopy. Ann. N.Y. Acad. Sci. 508: 130-148, 1987. 
31. Ramasamy, R., Mota de Freitas, D.E., Geraldes, C.F.G.C., Peters, J.A.: Multinuclear 
NMR study of the interaction of the shift reagent lanthanide(III) bis(triphosphate) with 
alkali-metal ions in aqueous solution and in the solid state. Inorg. Chem. 30: 3188-
3191, 1991. 
32. Mota de Freitas, D.E., Espanol, M.T., Ramasamy, R., Labotka, R.J.: Comparison of 
u+ transport and distribution in human red blood cells in the presence and absence of 
Dysprosium(III) complexes of triphosphate and triethylenetetraminehexaacetate. Inorg. 
Chem. 29: 3972-3979, 1990. 
33. Ramasamy, R., Mota de Freitas, D.E., Jones, W., Wezeman, F., Labotka, R., 
Geralders, C.F.G.C.: Effects of negatively charged shift reagents on red blood cell 
morphology, u+ transport, and membrane potential. Inorg. Chem. 29: 3980-3985, 
1990. 
34. Espanol, M.T., Mota de Freitas, D.E.: 7Li NMR studies of lithium trasnport in human 
erythrocyte. Inorg. Chem. 26: 4356, 1987. 
35. Ramasamy, R., Espanol, M.C., Long, K.M., Mota de Freitas, D.E., Geraldes, 
C.F.G.C.: Aqueous shift reagents for 7Li NMR trasnport studies in cells. Inorg. Chim. 
Acta. 163: 41-52, 1989. 
36. Pettegrew, M.W., Post, J.F.M., Panchaligam, K., Withers, G., Woessner, D.E.: 7Li 
NMR study of normal human erythrocytes. J. Magn. Reson. 71: 504-519, 1987. 
86 
37. Mota de Freitas, D.E., Espanol, M.T., Rong, Q.: 7Li NMR relaxation studies of Li+ 
ion interactions with human erythrocyte membrane components. In preparation. 
38. Gadian, D.G.: Nuclear Magnetic Resonance and its Application to Living Systems. 
Oxford: Clarendon Press, p 113, 1982. 
39. Canessa, M.: Kinetic properties of Na+ -H+ exchange and u+ -Na+, Na+ -Na+, and Na+ -
Li+ exchanges of human red cells. Methods Enzymol. ill: 176-191, 1989. 
40. Magnuson, J.A., Shelton, D.S., Magnuson, N.S.: A nuclear magnetic resonance study 
of sodium ion interaction with erythrocyte membranes. Biochem. Biophys. Res. 
Commun. J.2.: 279-283, 1970. 
41. Ong, R.L., Cheung, H.C.: 23Na-NMR studies of Na+ interaction with human red cell 
membranes from normotensives and hypertensives. Biophys. Chem. 23: 237-244, 1986. 
42. Urry, D.W., Trapane, T.L., Andrews, S.K., Long, M.M., Overbeck, H.W., Oparil, 
S.: NMR observation of altered sodium interaction with human erythrocyte membrane 
of essential hypertensives. Biochem. Biophys. Res. Commun. 96: 514-521, 1980. 
43. Nissen, H., Jacobsen, J.P., Horder, M.: Assessment of the NMR visibility of 
intraerythrocytic sodium by flame photometric and ion-competitive studies. Magn. 
Reson. Med. 10: 388-398, 1989. 
44. Labotka, R.J., Kleps, R.A.: A phosphate-analogue probe of red cell pH using 
phosphorus-31 nuclear magnetic resonance. Biochemistry 22: 6089-6095, 1983. 
45. Labotka, R.J.: Measurement of intracellular pH and deoxyhemoglobin concentration in 
deoxygenated erythrocytes by phophorus-31 nuclear magnetic resonance. Biochemistry 
23: 5549-5555, 1984. 
46. Petersen, A., Jacobsen, J.P., Horder, M.: 31P NMR measurements of intracellular pH 
in erythrocytes: Direct comparison with measurements using freeze-thaw and 
investigation into the influence of ionic strength and Mg2+. Magn. Reson. Med. ~: 341-
350, 1987. 
47. Steck, T.L., Kant, J .A.: Preparation of impermeable ghosts and inside-out vesicles from 
human erythrocyte membranes. Methods Enzymol. .ll: 172-177,1974. 
48. Pike, M.M., Yarmuch, D.M., Balschi, J.A., Lenkinski, R.E., Springer, C.S.: Aqueous 
shift reagents for high resolution cationic nuclear magnetic resonance. II. Mg-25, K-
39, and Na-23 resonances shifted by chelidamate complexes of dysprosium (III) and 
thulium (III). Inorg. Chem. 22: 2388, 1983. 
49. Bollag, D.M., Edelstein, S.J.: Protein Methods Wiley-Liss: pp 50-55, 1991. 
50. Dozy, A.M., Kleihauer, E.F., Huisman, T.H.: Studies on the heterogeneity of 
87 
hemoglobin. J. Chromatography Jl: 723, 1968. 
51. Agre, P., Parker, J.C.: Red Blood Cell Membranes. Structure. Function. Clinical 
Implications. Marcel Dekker, Inc., pp 538, 1989. 
52. Cantor, C., Schimmel, P.: Biophysical Chemistry. Freeman, pp 963-964, 1980. 
53. James, T.L., Noggle, J .H.: 2'.lNa nuclear magnetic resonance relaxation studies of 
sodium ion interaction with soluble RNA. Proc. Natl. Acad. Sci. USA @.: 644-649, 
1969. 
VITA 
The author, Suilan Mo, was born May 6, 1965, in Chongqing, China. 
In September, 1982, she entered China's University of Science and Technology and 
received the Bachelor Degree of Science with a major in Chemistry in June, 1987. 
In January 1990, she joined Loyola University of Chicago to pursue graduate studies 
in Chemistry. She was awarded a teaching assistantship from January 1990 to May 1991. She 
was supported by a research assistantship as part of a research grant awarded to Dr. Duarte 
Mota de Freitas by the National Institute of Mental Health from June 1991 to February, 1992. 
88 
APPROVAL SHEET 
The thesis submitted by Suilan Mo has been read and approved by the following committee: 
Dr. Duarte Mota de Freitas, Director 
Associate Professor of Chemistry, Loyola 
Dr. Kenneth Olsen 
Professor of Chemistry, Loyola 
Dr. Daniel Graham 
Assistant Professor of Chemistry, Loyola 
The final copies have been examined by the director of the thesis and the signature which 
appears below verifies the fact that any necessary changes have been incorporated and that the 
thesis is now given final approval by the committee with reference to content and form. 
The thesis is, therefore, accepted in partial fulfillment of the requirements for the degree of 
Master of Science. 
